BIOMODAL
LIVE

Serial Number

79391602

Owner

Biomodal Limited

Attorney

Rebecca Liebowitz

Filing Date

Oct 17, 2023

Add to watchlist:

No watchlists yet
View on USPTO

BIOMODAL Trademark

Serial Number: 79391602 • Registration: 8190636

BIOMODAL is a trademark filed by Biomodal Limited on October 17, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Biomodal Limited (4 trademarks)

B400 The Trinity Building,

Entity Type: 99

Cambridge Epigenetix Limited (5 trademarks)

Jonas Webb Building, Babraham Campus

Entity Type: 99

Trademark Details

Filing Date

October 17, 2023

Registration Date

March 31, 2026

Published for Opposition

February 10, 2026

Goods & Services

Diagnostic preparations for scientific research purposes; diagnostic preparations for scientific or research use other than for medical use; reagents for scientific research use; chemical reagents for scientific purposes; chemicals for use in scientific epigenetic research; chemicals for use in scientific analysis, other than medical or veterinary use; chemicals for use in the preparation and analysis of DNA and DNA extracts for use in science; chemical preparations to oxidate and bisulfite DNA extracts for use in science; PCR (Polymerase Chain Reaction) reagents for scientific and research use; nucleic acid sequences, namely, DNA primers, other than for medical or veterinary purposes; biochemical preparations for scientific purposes; biochemicals for in vitro and in vivo scientific use; biomolecule labelling kits comprising reagents for use in scientific research; chemical preparations for diagnostic use all for scientific research purposes; diagnostic preparations for medical research purposes; reagents for medical research use; chemical preparations for use in medical epigenetic research

Surgical, medical and veterinary apparatus and instruments, namely, medical diagnostic apparatus for testing DNA samples; apparatus for clinical diagnosis used to identify, sequence and measure DNA; medical diagnostic apparatus for the detection of mutations in genes and genetic predispositions; medical test kits comprising medical sample tubes, medical vials, medical diagnostic reagents, electrical sensors, optical sensors, and chemical sensors used for the detection of mutations in genes and genetic predispositions; apparatus for taking blood samples; blood testing apparatus; parts and fittings for all the aforesaid goods, namely, structural parts and fittings for medical diagnostic apparatus and instruments for testing, analysing, identifying, sequencing and measuring DNA samples

Scientific and technological services, namely, medical and veterinary research and DNA analysis services for scientific research purposes; industrial analysis and research services, namely, industrial DNA analysis services for scientific research purposes; research and development in the field of biotechnology, biology and chemistry; scientific investigations for medical purposes; scientific laboratory services; scientific research; scientific research and analysis in the field of identification of genetic and epigenetic markers and the diagnosis and treatment of diseases with a genetic component; scientific research and development; scientific research for medical purposes; scientific research for medical purposes in the area of cancerous diseases; scientific research in the field of genetics and genetic engineering; scientific research relating to bacteriology; scientific research relating to biology; scientific research relating to chemistry; scientific research relating to genetics; scientific research relating to genetics of plants; scientific research services; scientific services, namely, scientific laboratory services; scientific services and research relating thereto, namely, DNA analysis and screening relating to the processing of DNA samples and analysis of DNA sequencing data; scientific testing services, namely, genetic and epigenetic testing for scientific research purposes; DNA screening for scientific research purposes; pharmaceutical research and development; scientific research and development services in the field of genetics, including epigenetics; genome research, namely, genetic scientific research and epigenetic scientific research; stem cell research; gene therapy research; genetic engineering services; genetic and epigenetic DNA analysis services for scientific research purposes; DNA methylation and DNA hydroxymethylation analysis services for scientific research purposes; nucleic acid sequence analysis for scientific research purposes; research services for the development of new products; design and development of computer hardware and software; design and development of computer hardware and software in the field of genetic and epigenetic services; provision of information and data relating to medical and veterinary research and development, namely, providing information about medical research and providing information relating to veterinary research; software as a service (SaaS) services featuring software for the analysis of DNA and other biological materials; software as a service (SaaS) services featuring software for scientific analysis relating to the fields of genetics and DNA analysis; providing of temporary use of non-downloadable computer software for the analysis of DNA and other biological materials; providing of temporary use of non-downloadable computer software for scientific analysis relating to the fields of genetics and DNA analysis; professional consultancy and advisory services relating to all of the aforementioned services, namely, medical research advice and scientific research consultancy

Scientific apparatus and instruments, namely, DNA sequencers, flow cells, test tubes, PCR plates and sample collection equipment, namely, wipes and swabs for use in diagnostic testing, not for medical purposes; scientific research and laboratory apparatus, educational apparatus and simulators, namely, laboratory apparatus for analysing genetic and epigenetic sequences; scientific apparatus and instruments, namely, laboratory apparatus and instruments for extracting, purifying, modifying, amplifying and sequencing DNA for the analysis of DNA and other biological materials, not for medical purposes; diagnostic testing apparatus and instruments, namely, laboratory apparatus for the sequencing of DNA samples; apparatus and instruments for genetic analysis, namely, laboratory devices for detecting genetic and epigenetic sequences; downloadable computer programs for analysing genetic sequences and DNA analysis, downloadable computer programs for analysing epigenetic sequences and DNA analysis, downloadable software for scientific analysis of genetic sequences, downloadable software for scientific analysis of epigenetic sequences and downloadable databases all relating to the fields of genetics and DNA analysis; downloadable computer software for analyzing DNA and other biological materials; parts and fittings for all the aforesaid goods, namely, parts and fittings for scientific apparatus and instruments for testing, analysing, identifying, sequencing and measuring DNA samples

Pharmaceutical and veterinary preparations for use in the identification of genetic and epigenetic markers and the diagnosis and treatment of diseases or conditions that are caused by or exacerbated by genetic and epigenetic factors; chemical and biological preparations for medical or veterinary purposes for use in the identification of genetic and epigenetic markers and the diagnosis and treatment of diseases or conditions that are caused by or exacerbated by genetic and epigenetic factors; diagnostic substances for medical and veterinary use; preparations for detecting mutations in genes and genetic predispositions for medical or veterinary purposes; stem cells for medical or veterinary purposes; biological and chemical reagents for medical or veterinary purposes; medical clinical and medical diagnostic reagents; chemical reagents for use in the preparation and analysis of DNA and DNA extracts for medical purposes; chemical preparations to oxidate and bisulfite DNA extracts for the treatment of diseases or conditions that are caused by or exacerbated by genetic and epigenetic factors; PCR (Polymerase Chain Reaction) reagents for medical use; DNA primers, namely, nucleic acid sequences for medical and veterinary purposes; all for medical purposes

Medical and veterinary services; medical and veterinary services relating to DNA, genetics and genetic testing; medical clinic, medical and surgical diagnostic services; personalised medical services tailored to patients based on genetic or other information; health care; medical and healthcare clinic services; physical therapy; pharmaceutical advice; hospitals being hospital services; medical equipment rental; professional consultancy and advisory services relating to all of the aforementioned services in the field of healthcare

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 31, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 31, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 10, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 10, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 4, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 15, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 15, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 15, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 15, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 15, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 19, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 19, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 19, 2025 TROA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 5, 2025 OPNX
REFUSAL PROCESSED BY IB
Aug 23, 2025 RFNT
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 20, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 20, 2025 OPNR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 6, 2025 RFCS
REFUSAL PROCESSED BY MPU
Aug 5, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 5, 2025 RFCR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 8, 2024 ADCH
NON-FINAL ACTION WRITTEN
Jun 4, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 3, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 26, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 22, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 21, 2024 REPR